N J L M

 
Subscribe Via RSS
  • Home
  • About
    Salient Features Bibliographic Information Abstracting and Indexing Specialties Covered Publisher Journal Policy
  • Issues
    Current Issue Online Ahead of Print Archive Forthcoming issue
  • Editorial
    Editorial Statements Editorial-PeerReview Process Editorial Board Publication Ethics & Malpractice Join us
  • Authors
    Submit an Article Manuscript Instructions Manuscript Assistance Publication Charges Paid Services Early Online Publication Service
  • Reviewers
    Apply as Reviewer Reviewers Acknowledgment
  • Search
    Simple Search Advanced Search
  • Member
    Register Login
  • Contact
  • Subscription
Original article / research
Year: 2019 Month: July Volume: 8 Issue: 3 Page: MO01 - MO03

Methicillin Resistance, Vancomycin Intermediate and Vancomycin Resistance b#bStaphylococcus aureusb?b Prevalence in a Tertiary Care Hospital of Punjab, India

 
Correspondence Kiranjeet Kaur, Amarjit Kaur Gill, Mandeep Kaur,
Dr. Kiranjeet Kaur,
H. No-7195, Street No-3, Ward no-2, Near Husnar Chownk, Bathinda-152101, Punjab, India.
E-mail: amandeep43160@gmail.com
:
Introduction: Multidrug resistance Staphylococcus aureus (S.aureus) is a very notorious pathogen to develop drug resistance. After methicillin, resistance to vancomycin and linezolid were being reported from various areas of the world including India which is a serious issue.

Aim: To determine prevalence of Methicillin Resistant S. aureus (MRSA), Vancomycin Intermediate S. aureus (VISA) and Vancomycin Resistant S. aureus (VRSA) in a tertiary care hospital of Punjab, India.

Materials and Methods: The study was conducted in a tertiary care hospital from June 2016 to May 2017. S. aureus isolated from various clinical samples were identified as per standard protocol. Antimicrobial susceptibility was done by Kirby bauer disc diffusion method. MRSA detection was done using 30 µg cefoxitin disc on Mueller Hinton Agar (MHA). Vancomycin resistance was determined by agar dilution method. Vancomycin MIC <2 µg/mL reported as sensitive, MIC 4-8 µg/mL reported as VISA and MIC >16 µg/mL reported as VRSA.

Results: Out of 162 S. aureus isolates, 85 (52.4%) were female and 77 (47.5%) were male patients. Maximum 96 (59.2%) S. aureus were isolated from pus and pus swab. An 83 (51.2%) were MRSA, 19 (11.7%) were VISA and 4 (2.46%) were VRSA. Ampicillin 130 (80.0%), ciprofloxacin 102 (62.9%), co-trimoxazole 100 (61.7%) and erythromycim 96 (59%) were most resistant whereas tigecycline 162 (100%) was most sensitive followed by linezolid 154 (95%) and tecoplanin 153 (94%).

Conclusion: There is high prevalence of MRSA and an increasing MIC of vancomycin is reported in S. aureus which is big challenge for antimicrobial therapy. Performing culture and sensitivity in infectious cases in the hospital will help in reserving these drugs for those cases where all other drugs are resistant.
 
[ FULL TEXT ]   |   [ ]
 
Print
  • Article Utilities

    • Readers Comments (0)
    • Article in PDF
    • Citation Manager
    • Article Statistics
    • Link to PUBMED
    • Print this Article
    • Send to a Friend
    • Go To Issues

      • Current Issue
      • Past Issues
  • Search Articles

    • Simple Search
    • Advance Search
  • Authors Facilities

    • Extensive Author Support
    • Submit Manuscript
    • ONLINE First Facility
    • NJLM Pre Publishing
  • Quick Links

    • REVIEWER
    • ACCESS STATISTICS
  • Users

    • Register
    • Log in
  • Pages

    • About
    • Issues
    • Editorials
    • Authors
    • Reviewers
    • Search
    • Contacts
  • Issues Archives

  • Affiliated Websites

    • JCDR Prepublishing
    • Neonatal Database Home
    • JCDR Neonatal Database download center